Skip to main content
. 2018 Jan 24;56(2):e01237-17. doi: 10.1128/JCM.01237-17

TABLE 3.

Performance of Xpert Flu+RSV Xpress versus ProFlu+ on NP swab specimens for CLIA-waived sites only

Specimen type (n)a Target No. of results by typeb
PPA (% [95% CI]) NPA (% [95% CI])
TP FP TN FN
Fresh (1,871) Influenza A virus 215 85 1,571 0 100 (98.3–100) 94.9 (93.7–95.9)
Influenza B virus 56 10 1,805 0 100 (93.6–100) 99.4 (99.0–99.7)
RSV 112 6 1,750 3 97.4 (92.6–99.5) 99.7 (99.3–99.9)
Preselected frozen (209) Influenza A virus 0 4 205 0 NAc 98.1 (95.2–99.5)
Influenza B virus 78 2 129 0 100 (95.4–100) 98.5 (94.6–99.8)
RSV 31 0 177 1 96.9 (83.8–99.9) 100 (97.9–100)
All NP swabs (2,080) Influenza A virus 215 89 1,776 0 100 (98.2–100) 95.2 (94.2–96.1)
Influenza B virus 134 12 1,934 0 100 (97.2–100) 99.4 (98.5–99.7)
RSV 143 6 1,927 4 97.3 (93.2–98.9) 99.7 (99.3–99.9)
a

Fresh, specimen prospectively collected from consented/assented subjects; preselected frozen, specimen deidentified, frozen, and known to be positive or negative for a specific analyte. n, number of specimens.

b

TP, true positive; FP, false positive; TN, true negative; FN, false negative.

c

NA, not applicable.